Sun Pharmaceutical declares 5-yr positive results for ILUMYA
Pharma major Sun Pharmaceutical Industries Limited has announced that one of its wholly owned subsidiaries presented positive, five-year Phase 3 data for ILUMYA (tildrakizumab-asmn)...
New findings on brain acquiring essential omega-3 fatty acids
Scientists at the National Institutes of Health and colleagues have developed a zebrafish model that provides new insight into how the brain acquires essential...
RedHill Biopharma expands manufacturing capacity of Opaganib for COVID-19 with Cosmo Pharma
RedHill Biopharma Ltd has announced a manufacturing agreement with Cosmo Pharmaceuticals NV.
According to the specialty biopharmaceutical company, the partnership is to further expand manufacturing...
Obstructive sleep apnea ups risk for long COVID
Among the Covid-19 hit people,, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without...
Glenmark Pharmaceuticals gets approvals from USFDA for generic Prograf capsules
Glenmark Pharmaceuticals Inc., USA has received final approval by the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1...
Godrej partners with India’s universal immunisation programme
Godrej Appliances will be commissioning vaccine refrigerators and deep freezers under the pan India programme by Ministry of Health & Family Welfare.
It has commissioned...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
Humanigen announces positive interim Phase 3 Data of Lenzilumab in Covid patients
Humanigen Inc has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with Covid-19.
Humanigen is a clinical stage biopharmaceutical company focused on...
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...